Portal Hypertension III
3. Auflage Dezember 2000
272 Seiten, Hardcover
Wiley & Sons Ltd
ISBN:
978-0-632-05918-8
John Wiley & Sons
Proceedings of the Third Baveno International Consensus Workshop on
Definitions, Methodology and Therapeutic Strategies.
The participants attempted to develop consensus definitions of
key events in portal hypertension and variceal bleeding, diagnostic
and therapeutic issues, and the complications of therapies for
portal hypertension, as well as producing updated guidelines. The
lectures summarized the consensus reached in the earlier workshops,
addressed two important new areas of research, and analyzed the
quality of trials in portal hypertension and other fields of
hepatology.
Contributors, ix.
Preface, XV.
Lecture.
What have we accomplished ? 1.
Session 1.
Definition of Key Events: Lets try again, 13.
Baveno III Consensus Statements.
Lecture.
Stellate Cells: Do they have a role in portal hypertension?.
Session 2.
Diagnosis of Portal Hypertension: How and When, 36.
Baveno III Consensus Statements.
Session 3A.
Portal Hypertension Gastrotherapy, 65.
Session 3B.
Gastric Varices, 76.
Session 4.
Preprimary Prophylaxis. Can (and should) we prevent the
formation and growth of varices ?.
Baveno III Consensus Statements.
Lecture.
Session 5.
Primary Prophylaxis, 127.
Session 6.
Treatment of the acute bleeding episode, 134.
Session 7.
Prevention of Recurrent Variceal Haemorrhage(Secondary
Prophylaxis), 170.
Section 8.
Complications in the Medical Treatment of Portal Hypertension,
180.
Lecture.
Quality of Randomized Clinical Trials in Portal Hypertension and
other Fields Hepatology, 204.
Session 9.
Methodology of Future Trials: Prognostic Stratification,
Health-Related Quality of Life and Health Economics, 219.
Baveno III Consensus Statements.
Index, 241
Preface, XV.
Lecture.
What have we accomplished ? 1.
Session 1.
Definition of Key Events: Lets try again, 13.
Baveno III Consensus Statements.
Lecture.
Stellate Cells: Do they have a role in portal hypertension?.
Session 2.
Diagnosis of Portal Hypertension: How and When, 36.
Baveno III Consensus Statements.
Session 3A.
Portal Hypertension Gastrotherapy, 65.
Session 3B.
Gastric Varices, 76.
Session 4.
Preprimary Prophylaxis. Can (and should) we prevent the
formation and growth of varices ?.
Baveno III Consensus Statements.
Lecture.
Session 5.
Primary Prophylaxis, 127.
Session 6.
Treatment of the acute bleeding episode, 134.
Session 7.
Prevention of Recurrent Variceal Haemorrhage(Secondary
Prophylaxis), 170.
Section 8.
Complications in the Medical Treatment of Portal Hypertension,
180.
Lecture.
Quality of Randomized Clinical Trials in Portal Hypertension and
other Fields Hepatology, 204.
Session 9.
Methodology of Future Trials: Prognostic Stratification,
Health-Related Quality of Life and Health Economics, 219.
Baveno III Consensus Statements.
Index, 241
Roberto deFranchis, MD, Policlinico Hospital, Milan, Italy.